- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03446170
Effect of Cigarette Pack Warnings and Packaging Among Young Adult Smokers
December 14, 2021 updated by: Darren Mays, Georgetown University
Examining the Impact of Cigarette Package Warnings and Packaging Regulations Among Young Adult Smokers
The objective of this study is to examine whether cigarette packaging regulations including graphic health warning labels on cigarette packs and requiring plain, unbranded packaging reduce the appeal of cigarettes and prompt young adult smokers to quit.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study includes young adult smokers ages 18 to 30.
Eligible participants are young adults ages 18 to 30 years inclusive who report smoking at least 100 lifetime cigarettes and now smoking on all or some days.
Participants must also reside in the metro Washington, DC area.
The first portion of the study is a within-subjects experiment simulating point of sale cigarette purchase behaviors based on 2 packaging features: (1) graphic warning messages framed to emphasize either the health benefits of quitting (i.e., gain framed) or the health risks of smoking (i.e., loss-framed) and (2) industry branded or plain (i.e., standardized unbranded) packaging.
In the second portion of the study, the same participants take part in a prospective experiment to determine the impact of graphic cigarette warning message framing (gain versus loss) and packaging (branded versus plain) on motivation to quit and smoking behavior.
Participants are randomized to use 1 of 4 experimentally adapted cigarette packs in place of their regular packs for 4 weeks, or to a control condition which will continue to use their regular packs.
All participants complete baseline and follow-up assessments and respond to daily mobile phone text message prompts on their personal mobile phones during the 4 week exposure period.
Participants complete follow-up assessments capturing motivation to quit, smoking behavior, and quit attempts at the conclusion of the 4 week exposure period and 1- and 3-months later.
Study Type
Interventional
Enrollment (Anticipated)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20007
- Georgetown University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ages 18 to 30 years
- Smoke at least 100 cigarettes in their lifetime
- Now smoke cigarettes on all or some days
- Reside in the Washington, DC metro area
- Willing to send and receive text messages on a personal mobile phone
Exclusion Criteria:
- No additional exclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Loss-framed, branded
Participants assigned to this arm use cigarette packs with loss-framed graphic warnings communicating the risks of smoking on branded packages.
|
This study tests the effects of graphic cigarette warning labels that include pictures and text, and plain or standardized packaging
|
|
Experimental: Loss-framed, plain
Participants assigned to this arm use cigarette packs with loss-framed graphic warnings communicating the risks of smoking on plain or standardized packages.
|
This study tests the effects of graphic cigarette warning labels that include pictures and text, and plain or standardized packaging
|
|
Experimental: Gain-framed, branded
Participants assigned to this arm use cigarette packs with gain-framed graphic warnings communicating the benefits of quitting smoking on branded packages.
|
This study tests the effects of graphic cigarette warning labels that include pictures and text, and plain or standardized packaging
|
|
Experimental: Gain-framed, plain
Participants assigned to this arm use cigarette packs with gain-framed graphic warnings communicating the benefits of quitting smoking on plain or standardized packages.
|
This study tests the effects of graphic cigarette warning labels that include pictures and text, and plain or standardized packaging
|
|
No Intervention: Control
Participants assigned to this arm use their regular cigarette packs and complete study measures only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cigarette purchase appeal
Time Frame: Baseline
|
The effects of graphic cigarette warnings and plain packaging on cigarette purchase appeal will be measured using data collected from a within-subjects experiment at baseline.
Participants are randomly assigned to compare each pair of packs from the experimental conditions versus a standard branded control pack.
For each pair, cigarette purchase appeal is measured with 5 valid questions assessing: 1) Which pack would you be most likely to buy? 2) Which pack is the most appealing?
3) Which pack attracts your attention?
4) Which pack contains cigarettes that are the most harmful to your health?
5) Which pack makes you think about the health risks of smoking?
|
Baseline
|
|
Motivation to quit smoking
Time Frame: At the conclusion of the 4 week exposure
|
Motivation to quit smoking is measured using a valid scale comprised of 4 questions.
Participants report how likely it is they will quit smoking completely, reduce the number of cigarettes they smoke, and talk to a friend, family member, or spouse/partner about quitting smoking.
Participants respond using options for definitely will not, probably will not, probably will, or definitely will for each question.
|
At the conclusion of the 4 week exposure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cigarette smoking behavior
Time Frame: At the conclusion of the 4 week exposure, and at 1- and 3-months post-exposure
|
Cigarettes smoked per day is measured using a single valid question assessing about how many cigarettes participants smoked each day, on average.
|
At the conclusion of the 4 week exposure, and at 1- and 3-months post-exposure
|
|
Smoking quit attempts
Time Frame: At the conclusion of the 4 week exposure, and at 1- and 3-months post-exposure
|
Attempts to quit smoking is measured using a single valid item asking participants how many times they stopped smoking for 1 day or longer because they were trying to quit.
|
At the conclusion of the 4 week exposure, and at 1- and 3-months post-exposure
|
|
Motivation to quit cigarette smoking.
Time Frame: At 1-month and 3-months post-exposure
|
Motivation to quit smoking is measured using a valid scale comprised of 4 questions.
Participants report how likely it is they will quit smoking completely, reduce the number of cigarettes they smoke, and talk to a friend, family member, or spouse/partner about quitting smoking.
Participants respond using options for definitely will not, probably will not, probably will, or definitely will for each question.
|
At 1-month and 3-months post-exposure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Johnson AC, Luta G, Tercyak KP, Niaura RS, Mays D. Effects of pictorial warning label message framing and standardized packaging on cigarette packaging appeal among young adult smokers. Addict Behav. 2021 Sep;120:106951. doi: 10.1016/j.addbeh.2021.106951. Epub 2021 Apr 13.
- Johnson AC, Turner MM, Simmens SJ, Evans WD, Strasser AA, Mays D. Mediational Effects on Motivation to Quit Smoking After Exposure to a Cigarette Pictorial Warning Label Among Young Adults. Ann Behav Med. 2022 Jul 12;56(7):737-748. doi: 10.1093/abm/kaab073.
- Johnson AC, Simmens SJ, Turner MM, Evans WD, Strasser AA, Mays D. Longitudinal effects of cigarette pictorial warning labels among young adults. J Behav Med. 2022 Feb;45(1):124-132. doi: 10.1007/s10865-021-00258-2. Epub 2021 Sep 23.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2014
Primary Completion (Actual)
August 31, 2020
Study Completion (Actual)
August 31, 2020
Study Registration Dates
First Submitted
February 12, 2018
First Submitted That Met QC Criteria
February 20, 2018
First Posted (Actual)
February 26, 2018
Study Record Updates
Last Update Posted (Actual)
January 4, 2022
Last Update Submitted That Met QC Criteria
December 14, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2014-1031
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
We will consider requests to share de-identified individual participant data by request and according to our study protocol and institutional data sharing policy.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use
-
Loma Linda UniversityUniversity of California, San Francisco; Riverside University Health System...RecruitingTobacco Use | Tobacco Use Cessation | Tobacco Use in ChildbirthUnited States
-
University of Mississippi Medical CenterNot yet recruitingTobacco Cessation
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Cessation | Tobacco Use | Tobacco Use Cessation | Tobacco Dependence | Tobacco AbstinenceUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Duke UniversityCompletedSmokeless Tobacco CessationUnited States
-
University of FloridaRecruitingTobacco Use | Nicotine UseUnited States
-
Harvard School of Public Health (HSPH)Boston University; Dana-Farber Cancer Institute; Dimagi Inc.; Narotam Sekhsaria...Completed
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
Clinical Trials on Graphic cigarette warning labels, plain packaging
-
University of California, San DiegoNot yet recruitingE Cigarette Use
-
University of North Carolina, Chapel HillStanford UniversityCompletedWeight StigmaUnited States
-
Chinese University of Hong KongNot yet recruitingObesity & Overweight
-
Duke UniversityCompleted
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompleted